The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis
Open accessAbstract
Objectives. To understand important changes in co-occurring opioid and nonopioid drug use (i.e., polysubstance use) within the opioid epidemic in the United States. Methods. We analyzed survey data on the past month co-use of prescription and illicit opioids and 12 nonopioid psychoactive drug classes from a national sample of 15 741 persons entering treatment of opioid use disorder. Results. Past-month illicit opioid use increased from 44.8% in 2011 to 70.1% in 2018, while the use of prescription opioids alone dropped from 55.2% to 29.9%, yet overall remained high (94.5% to 85.2%). Past-month use of at least 1 nonopioid drug occurred in nearly all participants (> 90%), with significant increases in methamphetamine (+85%) and decreases across nonopioid prescription drug classes (range: −40% to –68%). Conclusions. Viewing opioid trends in a “silo” ignores the fact not only that polysubstance use is ubiquitous among those with opioid use disorder but also that significant changes in polysubstance use should be monitored alongside opioid trends. Public Health Implications. Treatment, prevention, and policymaking must address not only the supply and demand of a singular drug class but also the global nature of substance use overall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731
Trends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,137
Self-citationVital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0865 · Cited by 873
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
Polysubstance use: diagnostic challenges, patterns of use and health
Connor, J. P., Gullo, M. J., White, A., & Kelly, A. B. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000069 · Cited by 461
“Every ‘Never’ I Ever Said Came True”: Transitions from opioid pills to heroin injecting
Mars, S. G., Bourgois, P., Karandinos, G., Montero, F., & Ciccarone, D. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.10.004 · Cited by 432
Gladden, R. M., Martinez, P., & Seth, P. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a2 · Cited by 426
Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016.
Hedegaard, H. B., Bastian, B. A., Trinidad, J. P., Spencer, M. R. T., & Warner, M. (2018) · PubMed · Cited by 394
Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.029 · Cited by 355
Self-citationCicero, T. J., & Ellis, M. S. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3043 · Cited by 237
Self-citationHeroin and Methamphetamine Injection: An Emerging Drug Use Pattern
Al-Tayyib, A., Koester, S., Langegger, S., & Raville, L. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1271432 · Cited by 203
Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo, B. (2017) · Addiction · doi:10.1111/add.13741 · Cited by 174
(2016) · PubMed · Cited by 145
COPLAN, P. M., Kale, H. P., Sandstrom, L., Landau, C., & Chilcoat, H. D. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3522 · Cited by 130
Primary care physicians’ perspectives on the prescription opioid epidemic
Kennedy-Hendricks, A., Busch, S. H., McGinty, E., Bachhuber, M., Niederdeppe, J., Gollust, S. E., Webster, D. W., Fiellin, D., & Barry, C. L. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.05.010 · Cited by 127
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update
Pichini, S., Solimini, R., Berretta, P., Pacifici, R., & Busardò, F. P. (2017) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000465 · Cited by 122
Moyo, P., Simoni‐Wastila, L., Griffin, B. A., Onukwugha, E., Harrington, D., Alexander, G. C., & Palumbo, F. B. (2017) · Addiction · doi:10.1111/add.13860 · Cited by 117
Connor, J. P., Gullo, M. J., Chan, G., Young, R. M., Hall, W., & Feeney, G. F. X. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00079 · Cited by 99
Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years
Timko, C., Han, X., Woodhead, E. L., Shelley, A. N., & Cucciare, M. A. (2018) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2018.79.799 · Cited by 90
Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons
Jarlenski, M., Barry, C. L., Gollust, S. E., Graves, A. J., Kennedy‐Hendricks, A., & Kozhimannil, K. B. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303825 · Cited by 85
Abuse-deterrent Opioid Formulations
Litman, R. S., Pagán, O. H., & Cicero, T. J. (2017) · Anesthesiology · doi:10.1097/aln.0000000000002031 · Cited by 75
Self-citationCicero, T. J., Kasper, Z. A., & Ellis, M. S. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.05.030 · Cited by 59
Self-citationHarocopos, A., Allen, B., & Paone, D. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.12.021 · Cited by 54
Cicero, T. J., & Ellis, M. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.014 · Cited by 44
Self-citationNotes from the Field: Fentanyl Drug Submissions — United States, 2010–2017
Springer, Y. P., Gladden, R. M., O’Donnell, J. K., & Seth, P. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6802a4 · Cited by 15
Research works printed but not linked: 4
- Centers for Disease Control and Prevention, 2011, MMWR Morb Mortal Wkly Rep, 60, 1487
- 10.5055/jom.2017.0415 · doi:10.5055/jom.2017.0415
- Warner M, 2016, Natl Vital Stat Rep, 65, 1
- Hedegaard H, 2018, Natl Vital Stat Rep, 67, 1
Cited by
One Is Not Enough: Understanding and Modeling Polysubstance Use
Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14688 · Cited by 202
Clinical Management of Opioid Withdrawal.
Torres‐Lockhart, K. E., Lu, T. Y., Weimer, M. B., Stein, M. R., & Cunningham, C. O. (2022) · Addiction · doi:10.1111/add.15818 · Cited by 57
Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.2539 · Cited by 38
Strickland, J. C., Gipson, C. D., & Dunn, K. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.835816 · Cited by 31
Metadata
- Authors
- Cicero, T. J., Ellis, M. S., & Kasper, Z. A.
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2020-02
- Volume
- 110
- Issue
- 2
- Pages
- 244-250
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- OpenAlex
- W2996755245
- Cited by
- 285
- References
- 29
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.